Quarterly report pursuant to Section 13 or 15(d)

Warrants

v3.8.0.1
Warrants
9 Months Ended
Sep. 30, 2017
Warrants [Abstract]  
WARRANTS
12. WARRANTS

 

On August 3, 2017, upon approval of the Company’s board of directors, the Company issued outside its 2015 Equity Plan, 30,000 warrants to purchase the Company’s common stock to consultants for services provided. These warrants are immediately vested, are exercisable at an exercise price of $1.00 per share and expire on August 3, 2021. The Company recognized $18,617 in compensation cost during the nine months ended September 30, 2017.

 

On August 3, 2017, the Company issued a warrant to purchase 2,000,000 shares of the Company’s common stock to Dr. Philip Frost for services to be provided under the terms of his service to the Strategic Advisory Board through April 2018. These warrants immediately vested, are exercisable at an exercise price of $1.00 per shares and expire on August 3, 2022. The Company recognized $1,445,252 in compensation cost during the nine months ended September 30, 2017.

 

The following table summarizes the assumptions used to estimate the fair value of the 2,030,000 warrants granted during 2017 as of re-measurement dates:

 

      2017  
         
  Expected dividend yield     0 %
  Expected volatility     190-212 %
  Risk-free interest rate     1.52 %
  Expected life of warrants     4-5 years   

 

For the year 2016, 60,000 common stock purchase warrants were granted to four consultants for services provided. Each warrant was granted with the exercise price of $2.91, which immediately vested, and the expiration date is April 27, 2019. The Company recognized $114,779 in compensation cost during the nine months ended September 30, 2016.

 

During 2016, 10,472 warrants expired that were issued in 2011 with exercise prices ranging between $141.00 and $404.50 on a post-reverse split basis.

  

The Company used the Black-Scholes warrant pricing model to estimate the fair value on the re-measurement dates of the 12,500 warrants that vested on June 10, 2017.

   

The following table summarizes the assumptions used to estimate the fair value of the 12,500 warrants granted during 2015 as of re-measurement dates:

 

      2017  
         
  Expected dividend yield     0 %
  Expected volatility     107 %
  Risk-free interest rate     1.53 %
  Expected life of warrants     1 year   

 

Under the Black-Scholes warrant pricing model, fair value of the 12,500 warrants granted during 2015 is estimated at $0 as of re-measurement dates. During the nine months ended September 30, 2017, $(3,467) compensation expense was recognized on these 12,500 warrants. 

 

The following table represents warrant activity as of and for the period ended September 30, 2017:

 

      Number of Warrants     Weighted
Average
Exercise Price per Share
    Weighted Average Contractual Life in Years     Aggregate Intrinsic Value  
  Outstanding – December 31, 2016     183,737     $ 7.35       2.70          
  Exercisable – December 31, 2016     171,237     $ 7.15       2.79     $ 0  
  Granted     2,030,000     $ 1.00                  
  Forfeited or Expired     0     $ 0                  
  Outstanding – September 30, 2017     2,213,737     $ 1.53       4.59     $ 0  
  Exercisable – September 30, 2017     2,213,737     $ 1.53       4.59     $ 0